Icon

THYQUIDITY (nda214047)- (100MCG/5ML)

LEVOTHYROXINE SODIUM AZURITY
100MCG/5ML
Yes Yes
2031-Aug-06 Expired
None None
None No
THYQUIDITY is levothyroxine sodium (T4) indicated for: • Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. • Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.
0 0 0
Total Other Developers 2
Drugs with Suitability No
100MCG/5ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.